Introduction: Nicholas F. Franano, based in Kansas City, MO, is recognized for his significant contributions to medical technology, particularly in the field of cardiovascular treatments. His innovative approach to addressing obstructed biological conduits has led to the development of a patent that seeks to enhance fluid transport in veins and arteries.

Latest Patents: Franano holds a patent titled "Methods for treating an artery or vein in a human subject." This invention outlines methods for treating obstructions in biological conduits by administering agents that can degrade the extracellular matrix of obstructing tissue. Notably, the patent details specific methods involving the delivery of enzymes capable of breaking down the components of obstruction, ultimately restoring normal fluid flow. It also highlights preventive measures such as dilating sections of conduits to reduce the risk of future obstruction.

Career Highlights: Franano is associated with Proteon Therapeutics, Inc., where he leverages his expertise to advance the understanding and treatment of vascular conditions. His work at the company not only demonstrates his commitment to innovation but also underscores the importance of practical applications of scientific research in addressing real-world health issues.

Collaborations: Throughout his career, Franano has likely engaged with a network of professionals in the medical and scientific fields, although specific collaborations are not detailed. These interactions typically enhance the innovation process, fostering the development of effective treatments and technologies that can be brought to market.

Conclusion: Nicholas F. Franano exemplifies the role of an inventor dedicated to pushing the boundaries of medical technology. His patented methods for treating obstructed arteries and veins represent a significant advancement in cardiovascular health, offering new hope for patients affected by these conditions. As he continues his work at Proteon Therapeutics, Inc., Franano's contributions will undoubtedly influence future innovations in the medical field.

Profile summary based on public USPTO records.